Genus PLC Director/PDMR Shareholding

RNS Number : 0238E

Genus PLC

12 September 2024

 

12 September 2024

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 11 September 2024, conditional nil-cost share options were granted under the Genus 2019 Performance Share Plan ('PSP') over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ended 30 June 2024, nil-cost share options were granted over ordinary shares under the Genus 2019 Deferred Share Bonus Plan ('DSBP') as listed in table B below.

 

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2024 Annual Report which will be published next month.

The price at which PSP and DSBP nil-cost share options have been granted was determined in accordance with the PSP and DSBP rules.

Genus further announces that, further to the vesting on 14 September 2023 of conditional nil-cost options granted in 2020 under the PSP, as listed in table C below; and conditional nil-cost options granted in 2020 under the DSBP as listed in table D below, Elena Rice, Chief Scientific Officer sold ordinary shares in Genus on 11 September 2024 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the balance of ordinary shares.

 

Conditional nil-cost options granted under the PSP were subject to relevant performance conditions, measured over a three-year performance period which commenced on 1 July 2020 and ended on 30 June 2023. Following assessment of the performance conditions, the Remuneration Committee determined that the awards would vest at 36% of the original grant and the balance of the awards have lapsed.

 

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the nil-cost option awards made, exercised and ordinary shares sold on 11 September 2024.

 

For further information please contact:

 

Genus:

Cara Guedeney, Deputy Company Secretary                                      Tel: [phone]

 

Table A - GELT 2019 Performance Share Plan Options

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1.    Jorgen Kokke 2.    Alison Henriksen 3.    Matt Culbertson 4.    Jim Low 5.    Jerry Thompson 6.    Elena Rice 7.    Angelle Rosata 8.    Dan Hartley
2.	Reason for the notification
a.	Position/status	1.    Chief Executive 2.    Chief Financial Officer 3.    Chief Operating Officer, Genus PIC 4.    Chief Operating Officer, Genus ABS 5.    Regional Director of ABS EMEA 6.    Chief Scientific Officer 7.    Chief Human Resources Officer 8.    Group General Counsel & Company Secretary
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Genus plc
b.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each.     GB0002074580
b.	Nature of the transaction	Award of nil-cost share options granted under the PSP over ordinary shares in Genus.
c.	Price(s) and volume(s)	Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s)   Volume(s) 1.    0p 73,251 2.    0p 53,705 3.    0p 30,491 4.    0p 26,572 5.    0p 25,452 6.    0p 26,713 7.    0p 24,203 8.    0p 25,510
d.	Aggregated information ·    Aggregated volume ·    Price	n/a
e.	Date of the transaction	2024-09-11
f.	Place of the transaction	Outside a trading venue.

 

Table B - GELT 2019 Deferred Share Bonus Plan Options

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	1.    Jorgen Kokke 2.    Alison Henriksen 3.    Matt Culbertson 4.    Jim Low 5.    Jerry Thompson 6.    Elena Rice 7.    Angelle Rosata 8.    Dan Hartley
2.	Reason for the notification
a.	Position/status	1.    Chief Executive 2.    Chief Financial Officer 3.    Chief Operating Officer, Genus PIC 4.    Chief Operating Officer, Genus ABS 5.    Regional Director of ABS EMEA 6.    Chief Scientific Officer 7.    Chief Human Resources Officer 8.    Group General Counsel & Company Secretary
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Genus plc
b.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each.     GB0002074580
b.	Nature of the transaction	Award of nil-cost share options granted under the DSBP following the compulsory deferral of 33% and 25% of annual bonus for Executive Directors and members of GELT respectively in respect of bonuses earned in the financial year ended 30 June 2024.
c.	Price(s) and volume(s)	Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.   Price(s)   Volume(s) 1.    0p 11,856 2.    0p 7,910 3.    0p 2,577 4.    0p 664 5.    0p 1,673 6.    0p 2,161 7.    0p 2,006 8.    0p 2,200
d.	Aggregated information ·    Aggregated volume ·    Price	n/a
e.	Date of the transaction	2024-09-11
f.	Place of the transaction	Outside a trading venue.

 

Table C - GELT 2019 Performance Share Plan Exercise

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Elena Rice
2.	Reason for the notification
a.	Position/status	Chief Scientific Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Genus plc
b.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Exercise of nil-cost options under the PSP.
c.	Price(s) and volume(s)	Price(s) Volume(s) 0p 3,996
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 0p 3,996
e.	Date of the transaction	2024-09-11
f.	Place of the transaction	Outside a trading venue.
5.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.
c.	Price(s) and volume(s)	Price(s) Volume(s) 1,853.94p 1,443
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 1,853.94p 1,443
e.	Date of the transaction	2024-09-11
f.	Place of the transaction	London Stock Exchange, Main Market (XLON)

 

Table D - GELT Deferred Share Bonus Plan Exercise

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Elena Rice
2.	Reason for the notification
a.	Position/status	Chief Scientific Officer
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Genus plc
b.	LEI	54930022EOITNKSIGH56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Exercise of nil-cost options under the DSBP.
c.	Price(s) and volume(s)	Price(s) Volume(s) 0p 1,696
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 0p 1,696
e.	Date of the transaction	2024-09-11
f.	Place of the transaction	Outside a trading venue.
5.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code		Ordinary shares of 10p each     GB0002074580
b.	Nature of the transaction	Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.
c.	Price(s) and volume(s)	Price(s) Volume(s) 1,853.92p 613
d.	Aggregated information ·    Aggregated volume ·    Price	Price(s) Volume(s) 1,853.92p 613
e.	Date of the transaction	2024-09-11
f.	Place of the transaction	London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHUUVVRSRUKAAR